Kai Kliiman

2.0k total citations
12 papers, 725 citations indexed

About

Kai Kliiman is a scholar working on Infectious Diseases, Epidemiology and Surgery. According to data from OpenAlex, Kai Kliiman has authored 12 papers receiving a total of 725 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Infectious Diseases, 9 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Kai Kliiman's work include Tuberculosis Research and Epidemiology (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Pneumonia and Respiratory Infections (5 papers). Kai Kliiman is often cited by papers focused on Tuberculosis Research and Epidemiology (11 papers), Pneumocystis jirovecii pneumonia detection and treatment (5 papers) and Pneumonia and Respiratory Infections (5 papers). Kai Kliiman collaborates with scholars based in Estonia, Italy and United States. Kai Kliiman's co-authors include Alan Altraja, Giovanni Battista Migliori, Christoph Lange, Daniela María Cirillo, Antonio Spanevello, Rosella Centis, Mario Raviǵlione, Luigi Ruffo Codecasa, Andrea Gori and O. S. Toungoussova and has published in prestigious journals such as The Lancet, Annals of Internal Medicine and European Respiratory Journal.

In The Last Decade

Kai Kliiman

12 papers receiving 707 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kai Kliiman Estonia 10 635 545 278 65 28 12 725
Medea Gegia United States 14 664 1.0× 527 1.0× 276 1.0× 98 1.5× 33 1.2× 21 788
Zaza Avaliani Georgia 13 455 0.7× 352 0.6× 223 0.8× 89 1.4× 34 1.2× 47 576
Nestani Tukvadze Georgia 19 705 1.1× 540 1.0× 267 1.0× 150 2.3× 64 2.3× 54 897
N. Sarita Shah United States 13 1.1k 1.7× 885 1.6× 450 1.6× 65 1.0× 25 0.9× 19 1.2k
Fuad Mirzayev Switzerland 11 543 0.9× 386 0.7× 215 0.8× 106 1.6× 35 1.3× 25 704
Xiaohui Hao China 13 484 0.8× 360 0.7× 228 0.8× 53 0.8× 16 0.6× 31 594
Yew Ww China 9 411 0.6× 369 0.7× 121 0.4× 74 1.1× 35 1.3× 21 561
Gregory Symons South Africa 9 694 1.1× 523 1.0× 276 1.0× 164 2.5× 47 1.7× 15 882
Lidya Chaidir Indonesia 12 303 0.5× 217 0.4× 231 0.8× 75 1.2× 17 0.6× 41 465
Veriko Mirtskhulava Georgia 11 448 0.7× 323 0.6× 167 0.6× 36 0.6× 12 0.4× 17 551

Countries citing papers authored by Kai Kliiman

Since Specialization
Citations

This map shows the geographic impact of Kai Kliiman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kai Kliiman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kai Kliiman more than expected).

Fields of papers citing papers by Kai Kliiman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kai Kliiman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kai Kliiman. The network helps show where Kai Kliiman may publish in the future.

Co-authorship network of co-authors of Kai Kliiman

This figure shows the co-authorship network connecting the top 25 collaborators of Kai Kliiman. A scholar is included among the top collaborators of Kai Kliiman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kai Kliiman. Kai Kliiman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Kurbatova, Ekaterina V., Tracy Dalton, Julia Ershova, et al.. (2015). Additional Drug Resistance of Multidrug-Resistant Tuberculosis in Patients in 9 Countries. Emerging infectious diseases. 21(6). 977–983. 11 indexed citations
2.
Kliiman, Kai, et al.. (2014). Factors signifying gender differences in clinical presentation of sarcoidosis among Estonian population. The Clinical Respiratory Journal. 10(3). 282–290. 17 indexed citations
3.
Rüütel, Kristi, Ave Talu, Katri Abel‐Ollo, et al.. (2013). Prevalence of IGRA-positivity and risk factors for tuberculosis among injecting drug users in Estonia and Latvia. International Journal of Drug Policy. 25(1). 175–178. 5 indexed citations
4.
Migliori, Giovanni Battista, Giovanni Sotgiu, Lia D’Ambrosio, et al.. (2012). TB and MDR/XDR-TB in European Union and European Economic Area countries: managed or mismanaged?. European Respiratory Journal. 39(3). 619–625. 49 indexed citations
5.
Dalton, Tracy, Peter Cegielski, Somsak Akksilp, et al.. (2012). Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study. The Lancet. 380(9851). 1406–1417. 163 indexed citations
6.
Floyd, Katherine, Raymond Hutubessy, Kai Kliiman, et al.. (2012). Cost and cost-effectiveness of multidrug-resistant tuberculosis treatment in Estonia and Russia. European Respiratory Journal. 40(1). 133–142. 31 indexed citations
7.
Rüütel, Kristi, et al.. (2011). Enhanced tuberculosis case detection among substitution treatment patients: a randomized controlled trial. BMC Research Notes. 4(1). 192–192. 8 indexed citations
8.
Kliiman, Kai & Alan Altraja. (2010). Predictors and mortality associated with treatment default in pulmonary tuberculosis.. PubMed. 14(4). 454–63. 64 indexed citations
9.
Kliiman, Kai & Alan Altraja. (2009). Predictors of poor treatment outcome in multi- and extensively drug-resistant pulmonary TB. European Respiratory Journal. 33(5). 1085–1094. 108 indexed citations
10.
Kliiman, Kai, et al.. (2009). Predictors of Extensively Drug-Resistant Pulmonary Tuberculosis. Annals of Internal Medicine. 150(11). 766–775. 46 indexed citations
11.
Migliori, Giovanni Battista, Christoph Lange, Rosella Centis, et al.. (2008). Resistance to second-line injectables and treatment outcomes in multidrug-resistant and extensively drug-resistant tuberculosis cases. European Respiratory Journal. 31(6). 1155–1159. 96 indexed citations
12.
Migliori, Giovanni Battista, Giorgio Besozzi, Enrico Girardi, et al.. (2007). Clinical and operational value of the extensively drug-resistant tuberculosis definition. European Respiratory Journal. 30(4). 623–626. 127 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026